Resources
Partner Organizations
Liverpool Associates in Tropical Health
Health & Development International
Schistosomiasis Control Initiative, Imperial College London
Liverpool Associates in Tropical Health
The Liverpool School of Tropical Medicine (LSTM) established Liverpool Associates in Tropical Health (LATH) in 1986, as an independent company to help it respond more effectively and efficiently to the increasing demand for international development assistance. As LSTM’s consulting arm, LATH is a gateway to internationally recognised research, channelling this expertise into influencing policy and transforming practice. LATH provides technical assistance through its in-house specialists, LSTM clinical and technical staff and a database of proven international and national consultants.
We are committed to working in partnership with our clients (government, donors, academic institutes, NGOs and private sector) in delivering effective solutions through:
- Ensuring sustainable and integrated capacity development with national partners
- Using evidence based policies and strategies
- Addressing problems within a wider health systems context
- Working within a pro-poor and gender equity framework
LATH’s technical expertise reflects the research and teaching strengths of LSTM. We can offer extensive clinical and technical expertise across a wide range of disciplines and in particular our key focus areas are laboratory systems strengthening; malaria control; human resources for health; maternal and neonatal health; neglected tropical diseases; decentralization, monitoring and evaluation.
Malaria Consortium
The Mission of Malaria Consortium is the relief of sickness among poor people suffering from diseases, particularly malaria, and the protection of health of poor people at risk of contracting such diseases.
Malaria Consortium aims to:
- Increase the delivery of services to hard-to-reach populations and vulnerable groups especially in post-conflict situations.
- Increase coverage with preventive interventions of the poorest populations.
- Improve access to effective treatment for those populations most affected and reduce mortality.
- Improve capacity in partner countries and organizations to control malaria & communicable diseases.
- Advocate for an increased and improved response to malaria & communicable diseases.
Malaria Consortium has supported delivery of effective disease control interventions and development of evidence-based policies and strategies in Africa and Asia for the last twelve years. These efforts have been led by a technical team with extensive experience in malaria, health systems strengthening, and neglected tropical diseases (NTDs), including onchocerciasis, lymphatic filariasis, intestinal worms, schistosomiasis, trachoma and visceral leishmaniasis.
The combination of high quality technical expertise and the ability to implement large-scale programs has made Malaria Consortium a key partner of many Ministries of Health in Africa and elsewhere. The organization routinely supports strategic planning on malaria and NTDs, as well as national program implementation. NTD support has been particularly extensive in Uganda, Ethiopia and Southern Sudan. In Uganda, a comprehensive situation analysis on NTDs was conducted with the Ministry of Health, operational research on visceral leishmaniasis has been completed and work is ongoing to establish the effectiveness of long-lasting insecticidal nets (LLINs) for lymphatic filariasis prevention. In Ethiopia, MC has supported the MoH in conducting a rapid assessment on the potential for integrated NTD control and is currently conducting large-scale mapping of schistosomiasis and soil-transmitted helminth (i.e. intestinal worms). Rapid progress has been made in supporting the MoH of Southern Sudan in establishing a national integrated NTD program with financial support from RTI/USAID. Disease mapping is ongoing and the first round of drug co-administration is scheduled for early 2009. This will be conducted through the Onchocerciasis Control Program’s existing structures for community-directed treatment with ivermectin (CDTI), targeting onchocerciasis, lymphatic filariasis, schistosomiasis, intestinal worms and trachoma. The goal is to expand the integrated NTD program from two initial target states to all endemic areas of Southern Sudan. Malaria Consortium also continues to support visceral leishmaniasis control in the major focus of Upper Nile in Southern Sudan.
Health & Development International
Health & Development International (HDI) is a small and innovative non-governmental organization whose mission is to advance world public health, strengthen economic development, and augment human dignity among some of the world’s most unfortunate people by helping to permanently free them of specific diseases. Established in 1990, HDI targets debilitating diseases that are deemed to be eradicable as public health problems but which have been insufficiently addressed at the time HDI becomes engaged.
HDI has been actively engaged in efforts to:
• eradicate guinea worm
• stop lymphatic filariasis transmission
• prevent deaths during childbirth and prevent obstetric fistula among survivors of obstructed labor
How HDI works
• HDI is small, agile and flexible, moving quickly to identify and solve problems creatively in a way that larger organizations may not.
• HDI distinguishes itself by serving as a catalyst, using modest funds to open bottlenecks and help bring together organizations that share the common goal of eradicating disease through practical, cost effective programs.
• HDI supports local efforts to educate populations and treat and prevent disease in ways designed to build health capacity and strengthen economic self-sufficiency.
• HDI believes in “south-to-south” collaborations in which experiences and information from one developing country are shared and applied in countries with similar problems.
• HDI complements and supplements the work of governments and other NGOs by filling in gaps in important programs, finding solutions to problems others have not solved, and acting quickly to respond to immediate needs.
• HDI works in close partnership with international organizations in the fight to eradicate disease. Partners include The Carter Center, U.S. Centers for Disease Control and Prevention, UNFPA, the World Health Organization, and corporations such as Merck and GlaxoSmithKline.
HDI’s experience with guinea worm eradication and reduction of lymphatic filariasis led, through collaboration with other experts in neglected tropical diseases, to a successful pilot of integrated control of neglected tropical diseases (NTDs) in Togo. Integrated control of NTDs is now being scaled up for implementation on the national level in Togo.
IMA World Health
What We Do
IMA World Health helps provide essential health care service and supplies, without bias, to people in need in developing countries.
We accomplish this through direct provision to hospitals, clinics, programs, and other health care provides, and by strengthening health systems through training, education, and oversight. Faith-based organizations are key partners in our work. We have consistently received top efficiency ratings from independent watchdog agencies such as Charity Navigator.
IMA World Health accomplishes its mission through partnerships with governments, Non-Governmental Organizations (NGOs), pharmaceutical and medical supply manufacturers, other faith-based organizations, service clubs, and global health agencies such as the U.S. Agency for International Development (USAID), The World Bank, and the Centers for Disease Control (CDC).
We are known for our work in:
- Integrated Health System Development
- Targeted Disease Control including HIV/AIDS, Malaria and Neglected Tropical Diseases (NTDs)
- Building capacity of national faith-based health systems including advocacy and networking
- Health Information Management Systems and Global Information Systems (Mapping)
- Procurement, shipment and distribution of pharmaceuticals, medical equipment and supplies
IMA and NTDs
IMA World Health has long recognized the hardship caused by NTDs and since 1994 has been actively implementing interventions in several countries to control and eliminate several of these diseases, particularly Onchocerciasis and Lymphatic Filariasis (LF).
Although IMA World Health first began working with stand-alone NTD programs in Tanzania, the Democratic Republic of Congo (DRC) and more recently in Haiti, our latest initiatives have recognized the cost-effectiveness of integrating two or more of the NTDs into a targeted package of interventions.
With funding from USAID through RTI International, IMA World Health is presently working with the Ministries of Health and Education in Haiti, the CDC, the University of Notre Dame, the Pan American Health Organization, Hospital Saint Croix, and other local partners for the implementation of an integrated program to eliminate LF and the deworming of children in 23 Communes in Northern Haiti. Simultaneously, IMA World Health is supporting NTD services in twelve additional Communes with funding from the Bill and Melinda Gates Foundation, through the University of Notre Dame.
Supported by a $1.2 million grant over a 3-year period, from USAID through the World Bank Trust Fund, IMA World Health is actively involved in LF morbidity management work at the community level in India and Togo. In the Orissa State of India, IMA World Health partners with the Church's Auxiliary for Social Action (CASA), a national faith-based organization, and the CDC in training patients and volunteers in managing the disabilities related to elephantiasis. In Togo, IMA World Health is collaborating directly with the Ministry of Health's National LF Elimination Program and the CDC, and provides a variety of morbidity management training to patients and volunteers throughout Togo.
Helen Keller International
Founded in 1915, Helen Keller International (HKI) is among the oldest international nonprofit organizations devoted to fighting and treating preventable blindness. Its mission is to save the sight and lives of the most vulnerable and disadvantaged. HKI combats the causes and consequences of blindness and malnutrition by establishing programs based on evidence and research in vision, health and nutrition. HKI is known for sustainability, reliability, efficiency, and the highest level of technical expertise in fighting and treating blindness and malnutrition. The hallmark of the organization’s work is its proven effectiveness in developing, testing and scaling-up health interventions, and integrating them within government and community structures.
Control of Neglected Tropical Diseases (NTDs) cuts across HKI’s two longstanding areas of program focus: Eye Health and Nutrition. The organization is one of the leading global experts in combating the two blinding NTDs, onchocerciasis and trachoma. HKI also has extensive involvement in controlling soil-transmitted helminthes combating schistosomiasis because of its link with anemia. The strategy to eliminate lymphatic filariasis is built on the community-based drug distribution strategy that HKI and partners helped to develop for onchocerciasis control.
Currently, HKI implements crosscutting strategies to combat NTDs in twelve countries in Africa (Burkina Faso, Cameroon, Côte d’Ivoire, the Democratic Republic of Congo, Guinea-Conakry, Mali, Mozambique, Niger, Nigeria, Senegal, Sierra Leone, and Tanzania), and two in Asia (Cambodia and Nepal). In addition to preventive chemotherapy, HKI also promotes measures to improve hygiene and sanitation practices that lead to sustainable NTD control and prevention.
HKI is a founding member or partner of the African Program for Onchocerciasis Control (APOC); VISION 2020; The Global Elimination of Blinding Trachoma (GET 2020), the International Coalition for Trachoma Control (ICTC); the Global Alliance for Elimination of Lymphatic Filariasis (GAELF); and others. HKI’s President and CEO is the Chair of the Global Network for Neglected Tropical Disease Control (GNNTDC).
For more information about HKI’s efforts to control NTDs, please visit: http://www.hki.org/programs/neglected_tropical_diseases.html
Schistosomiasis Control Initiative, Imperial College London
In 2002 the Bill and Melinda Gates Foundation’s Global Health Programme* granted a $30 million award to establish the SCI at Imperial College London. The award has been directed to delivering treatment for schistosomiasis and intestinal worms to millions of sub-Saharan Africans at high risk of serious disease. In 2006, the SCI was a founding partner of the Global Network for Neglected Tropical Disease Control (www.gnntdc.org) and expanded its remit to integrating the control or elimination of seven NTDs. By 2007, the SCI has facilitated delivery of approximately 40 million treatments of praziquantel against schistosomiasis, and many more deworming doses of albendazole. We have helped eight countries establish national control programmes, and several other countries implement smaller pilot projects.The mission of the SCI is to help those who suffer from and are at risk of NTDs in sub-Saharan
- Creating awareness, changing perceptions and fostering global support for National NTD Programmes;
- Promoting effective collaboration and developing key partnerships in order to mobilize resources against NTDs;
- Empowering governments to run successful and sustainable National NTD Control Programmes;
- Ensuring universal access to effective treatment to everyone who suffers from NTDs;
- Building the capacity of civil society and affected communities to break the cycle of transmission;
- Developing and deploying a new generation of improved preventative and therapeutic tools and strategies to eliminate NTDs.
The goal of the SCI is to reduce the global disease burden of NTDs in sub-Saharan
In order to achieve this we need to control and eliminate these diseases as public health problems, hence improve childhood development, school attendance and performance, pregnancy outcomes, and worker productivity among the world's poorest populations.
World Vision is a Christian humanitarian charity organization dedicated to working with children, families, and their communities worldwide to reach their full potential by tackling the causes of poverty and injustice. We serve close to 100 million people in nearly 100 countries around the world. World Vision serves all people, regardless of religion, race, ethnicity, or gender. World Vision is a global organization with offices in approximately 100 countries. These interdependent national offices are bound together by a Covenant of Partnership, a biblically based agreement that enables us to work together in a unified and complementary way as we walk alongside those we serve. The millions of people we serve include earthquake and hurricane survivors, abandoned and exploited children, survivors of famine and civil war, refugees, and children and families in communities devastated by AIDS in Africa, Asia, and Latin America.
Our extensive global infrastructure enables us to respond where the need is greatest, anywhere in the world.
